ITMI20020773A1 - Farmaci per il trattamento dell'artrite - Google Patents

Farmaci per il trattamento dell'artrite

Info

Publication number
ITMI20020773A1
ITMI20020773A1 IT2002MI000773A ITMI20020773A ITMI20020773A1 IT MI20020773 A1 ITMI20020773 A1 IT MI20020773A1 IT 2002MI000773 A IT2002MI000773 A IT 2002MI000773A IT MI20020773 A ITMI20020773 A IT MI20020773A IT MI20020773 A1 ITMI20020773 A1 IT MI20020773A1
Authority
IT
Italy
Prior art keywords
arthritis
drugs
treatment
Prior art date
Application number
IT2002MI000773A
Other languages
English (en)
Italian (it)
Inventor
Soldato Piero Del
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Priority to IT2002MI000773A priority Critical patent/ITMI20020773A1/it
Publication of ITMI20020773A0 publication Critical patent/ITMI20020773A0/it
Priority to PCT/EP2003/003183 priority patent/WO2003084550A1/en
Priority to JP2003581790A priority patent/JP2005522472A/ja
Priority to EP03720377A priority patent/EP1492543A1/en
Priority to US10/509,675 priority patent/US20070010458A1/en
Priority to AU2003224002A priority patent/AU2003224002A1/en
Publication of ITMI20020773A1 publication Critical patent/ITMI20020773A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2002MI000773A 2002-04-11 2002-04-11 Farmaci per il trattamento dell'artrite ITMI20020773A1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT2002MI000773A ITMI20020773A1 (it) 2002-04-11 2002-04-11 Farmaci per il trattamento dell'artrite
PCT/EP2003/003183 WO2003084550A1 (en) 2002-04-11 2003-03-27 Drugs for the arthritis treatment
JP2003581790A JP2005522472A (ja) 2002-04-11 2003-03-27 関節炎の治療用薬剤
EP03720377A EP1492543A1 (en) 2002-04-11 2003-03-27 Drugs for the arthritis treatment
US10/509,675 US20070010458A1 (en) 2002-04-11 2003-03-27 Drugs for the arthritis treatment
AU2003224002A AU2003224002A1 (en) 2002-04-11 2003-03-27 Drugs for the arthritis treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000773A ITMI20020773A1 (it) 2002-04-11 2002-04-11 Farmaci per il trattamento dell'artrite

Publications (2)

Publication Number Publication Date
ITMI20020773A0 ITMI20020773A0 (it) 2002-04-11
ITMI20020773A1 true ITMI20020773A1 (it) 2003-10-13

Family

ID=11449687

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI000773A ITMI20020773A1 (it) 2002-04-11 2002-04-11 Farmaci per il trattamento dell'artrite

Country Status (6)

Country Link
US (1) US20070010458A1 (https=)
EP (1) EP1492543A1 (https=)
JP (1) JP2005522472A (https=)
AU (1) AU2003224002A1 (https=)
IT (1) ITMI20020773A1 (https=)
WO (1) WO2003084550A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2393724A1 (en) 1999-12-23 2001-06-28 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
WO2003103602A2 (en) 2002-06-11 2003-12-18 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
CA2491127A1 (en) 2002-07-03 2004-01-15 Nitromed, Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US8173840B2 (en) 2003-07-29 2012-05-08 Signature R&D Holdings, Llc Compounds with high therapeutic index
US7589233B2 (en) 2003-07-29 2009-09-15 Signature R&D Holdings, Llc L-Threonine derivatives of high therapeutic index
WO2005065361A2 (en) * 2003-12-31 2005-07-21 Khosrow Kashfi Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
EP1711457A4 (en) 2004-01-27 2008-01-09 Merck Frosst Company NITROGEN MONOXIDE RELEASING PRODRUGS OF DIARYL-2- (5H) FURANOES AS INHIBITORS OF CYCLOOXYGENASE-2
CN1914169A (zh) 2004-01-27 2007-02-14 默克弗罗斯特公司 作为环氧合酶－2抑制剂的二芳基－2－(5h)－呋喃酮的氧化氮释放前药
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
AR054181A1 (es) 2004-08-26 2007-06-06 Nicholas Piramal India Ltd Prodrogas que contienen enlaces bio-divisibles. composiiciones farmaceuticas
US7586003B2 (en) * 2005-07-14 2009-09-08 Zinpro Corporation Derivatives of seleno-amino acids
US8236820B2 (en) 2007-08-10 2012-08-07 Basil Rigas Anti-inflammatory compounds and uses thereof
EP2188245B1 (en) 2007-08-17 2013-11-06 Council of Scientific & Industrial Research Nitric oxide releasing derivatives of paracetamol
CA2897571C (en) 2013-01-21 2018-12-18 Apparao Satyam Nitric oxide releasing prodrugs of therapeutic agents containing at least one carboxylic acid group
CN108864008B (zh) * 2017-05-09 2021-10-22 江苏康缘药业股份有限公司 一种橙酮类化合物及其制备方法与应用
CN111116529A (zh) * 2020-01-13 2020-05-08 江苏康缘药业股份有限公司 一种具有抗炎作用的化合物及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2998450A (en) * 1958-05-19 1961-08-29 Warner Lambert Pharmaceutical Process of preparing nu-acetyl-p-amino phenol
AT290523B (de) * 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
US3600437A (en) * 1969-05-28 1971-08-17 Lilly Co Eli Substituted phenylalkanoic acids and derivatives thereof
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3784701A (en) * 1970-09-21 1974-01-08 American Cyanamid Co Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain
US3843681A (en) * 1971-06-01 1974-10-22 American Home Prod 1-carboxamido pyrano(thiopyrano)(3,4-6)indole derivatives
US4035376A (en) * 1972-10-24 1977-07-12 Janssen Pharmaceutica N.V. Aroyl-substituted phenylacetic acid derivatives
US3997669A (en) * 1972-12-26 1976-12-14 Ciba-Geigy Corporation Tertiary aminoacids
US4061779A (en) * 1973-09-11 1977-12-06 Beecham Group Limited Naphthalene derivatives having anti-inflammatory activity
US4161538A (en) * 1977-04-05 1979-07-17 Sankyo Company Limited Substituted phenylacetic acid derivatives and process for the preparation thereof
IT1256450B (it) * 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
SI0759899T1 (en) * 1994-05-10 1999-12-31 Nicox S.A. Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
DE4420523A1 (de) * 1994-06-13 1995-12-14 Cassella Ag Verwendung von NO-freisetzenden Verbindungen zur Behandlung und Vorbeugung von systemischen Entzündungssyndromen
JP2004509967A (ja) * 2000-09-25 2004-04-02 ザ、プロクター、エンド、ギャンブル、カンパニー 医学及び治療法の適用に使用するための金属錯体
US7125564B2 (en) * 2001-02-16 2006-10-24 Lavipharm Laboratories, Inc. Water soluble and palatable complexes

Also Published As

Publication number Publication date
AU2003224002A1 (en) 2003-10-20
JP2005522472A (ja) 2005-07-28
ITMI20020773A0 (it) 2002-04-11
EP1492543A1 (en) 2005-01-05
WO2003084550A1 (en) 2003-10-16
US20070010458A1 (en) 2007-01-11

Similar Documents

Publication Publication Date Title
PL364865A1 (pl) Zastosowanie inhibitorów monoaminoksydazy do wytwarzania leków przeznaczonych do leczenia otyłości
AU2003285091A8 (en) Interferon antagonists useful for the treatment of interferon related diseases
CY2015025I1 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DE60333294D1 (de) Kontrollierte verabreichung von arzneien
NO20043237L (no) Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser
IS8142A (is) Læknislyf gagnleg til meðferðar á verkjum
ITTO20040621A1 (it) Immunogeno sintetico per la terapia e profilassi dell'abuso di droghe e sostanze psicoattive
ITMI20020773A1 (it) Farmaci per il trattamento dell'artrite
IL166217A0 (en) Combination of drugs for the treatment of neoplasms
FR2846545B1 (fr) Implant d'osteosynthese intramedullaire
NO20033803D0 (no) Karbamat for behandling av bevegelseslidelser
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
EP1568691A4 (en) ACCELERATOR FOR ERYTHROPOETIN PRODUCTION
DE60332134D1 (de) Gerät zwecks hämodynamischbasierter optimierung der kardialen stimulation
ITMI20011307A0 (it) Farmaci per l'epilessia
DK1553950T3 (da) Terapeutisk behandling
ITMI20010077A0 (it) Procedimento per la produzione dell'imipenem
ITPD20020251A1 (it) Dispositivo per l'ottimizzazione dell'innesto di
ITMI20011284A0 (it) Composizione farmaceutica per il trattamento dell'iperfosfatemia
ITRM20010136A0 (it) Composti utili per il trattamento di patologie che rispondono all'attivazione del recettore ppar-gamma.
ITRM20030573A1 (it) Dispositivo per la regolazione dell'orientamento di un
ITMI20011378A0 (it) Composizione farmaceutica per il trattamento dell'iperfosfatemia
ITMI20022594A1 (it) Combinazione terapeutica per la cura dell'ipertensione.
ITMI20022678A1 (it) Negativoscopio con mezzi di mascheratura dell'area di